A disciplined, research-driven value strategy built on independent fundamental analysis, rigorous process, and a structure designed to think differently.
Maximize return by buying improving companies at reasonable valuations.
Prefer underappreciated quality where the market may not fully reflect the improvement path — the mispricing of the trajectory, not the absolute quality tier.
Underappreciated level of quality, whether high or low — what matters is that the improvement trajectory is not reflected in the price.
Favor conservative balance sheets and resilient cash-generation profiles that preserve optionality through the cycle.
Manage risk actively through position sizing, portfolio construction discipline, and ongoing thesis validation — not by avoiding it.
At different points in the company cycle, we care about different things — overinvestment risk at the top, underinvestment risk at the bottom.
Avoid over-investment at peaks; ensure capital deployment is accretive.
Avoid under-investment in troughs; ensure management is looking long term.
What we look for — and what we avoid.
Improving business fundamentals at prices that may not reflect intrinsic value.
Prefer underappreciated quality — the mispricing is in the trajectory, not the absolute quality tier.
Identifiable catalysts that may drive revaluation, underwritten conservatively.
Conservative balance sheets and resilient cash-generation profiles that preserve optionality.
Favor companies where management is investing for the long term, not over-spending at peaks or retreating at troughs.
Strong relations with the firm and sponsor team. Deliberate focus on team stability — turnover, continuity, and succession planning. Experienced advisors provide accountability and long-term institutional continuity.
Buy: thesis-driven with documented catalysts, assumptions, and risk factors before capital is committed. Trim: scale back when valuation reaches or exceeds fair value, not on price momentum. Sell: clear criteria for thesis invalidation — exit when the original case no longer holds.
Position sizing discipline: add or trim at ±8% thresholds to enforce conviction-based sizing. Documented decision-making ensures accountability and enables learning from every trade. Portfolio construction balances concentration with diversification.
Value is the discipline of paying less than something is worth — across all quality tiers.
We are not restricted to low-multiple, distressed, or "cheap" companies. Value, in our framework, means buying any company — high quality or low — where the price does not fully reflect the improvement trajectory. The discipline is in the underwriting: conservative assumptions, identifiable catalysts, and a clear view of downside before any capital is committed.
Buying improving companies before the market prices in the improvement.
Relative valuation — what is the market expecting vs. what we expect?
Patience to wait for the mispricing; discipline to sell when it resolves.
Most funds optimize for consensus. We are built to challenge it — through a structure that rewards intellectual honesty, a process that enforces discipline, and a team rotation model that creates same-week feedback loops unavailable in most professional seats. Philosophy, process, and structure all ladder up to the same outcome: a repeatable, differentiated approach to finding companies the market has mispriced.
